Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice

Role of YAP/TAZ in mechanotransduction

Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979 · see citing works

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · see citing works

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · see citing works

Fibrotic disease and the TH1/TH2 paradigm

Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765 · see citing works

Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling

Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628 · see citing works

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443 · see citing works

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF ^β-TRCP

Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418 · see citing works

YAP1 increases organ size and expands undifferentiated progenitor cells

Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252 · see citing works

The emerging roles of YAP and TAZ in cancer

Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,156 · see citing works

Yap1 acts downstream of α-catenin to control epidermal proliferation

Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036 · see citing works

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

Zhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 916 · see citing works

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

Johnson, R. L., & Halder, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 884 · see citing works

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874 · see citing works

Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs

Henderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866 · see citing works

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.

Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859 · see citing works

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression

Liu, F., Mih, J. D., Shea, B. S., Kho, A. T., Sharif, A. S., Tager, A. M., & Tschumperlin, D. J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201004082 · Cited by 799 · see citing works

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G. A., Finegold, M. J., Lee, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721 · see citing works

Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis

Georges, P. C., Hui, J.-J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., Mick, R., Janmey, P. A., Furth, E. E., & Wells, R. G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00032.2007 · Cited by 577 · see citing works

High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers

Mederacke, I., Dapito, D. H., Affò, S., Uchinami, H., & Schwabe, R. F. (2015) · Nature Protocols · doi:10.1038/nprot.2015.017 · Cited by 541 · see citing works

Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma

Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528 · see citing works

An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis

Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12008 · Cited by 523 · see citing works

The Compliance of Collagen Gels Regulates Transforming Growth Factor-β Induction of α-Smooth Muscle Actin in Fibroblasts

Arora, P. D., Narani, N., & McCulloch, C. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65334-5 · Cited by 465 · see citing works

YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis

Szeto, S. G., Narimatsu, M., Lu, M., He, X., Sidiqi, A. M., Tolosa, M. F., Chan, L., Freitas, K. D., Bialik, J. F., Majumder, S., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050499 · Cited by 463 · see citing works

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

Luukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461 · see citing works

Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

Chaurasia, B., Tippetts, T. S., Mayoral, R., Liu, J., Li, Y., Wang, L., Wilkerson, J. L., Sweeney, C. R., Pereira, R. F., Sumida, D. H., et al. (2019) · Science · doi:10.1126/science.aav3722 · Cited by 453 · see citing works

Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis

Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413 · see citing works

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.011 · Cited by 410 · see citing works

Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies

de Graaf, I. A. M., Olinga, P., de Jager, M. H., Merema, M. T., de Kanter, R., van de Kerkhof, E. G., & Groothuis, G. M. M. (2010) · Nature Protocols · doi:10.1038/nprot.2010.111 · Cited by 409 · see citing works

“Sternzellen” in the liver: Perisinusoidal cells with special reference to storage of vitamin A

Wake, K. (1971) · American Journal of Anatomy · doi:10.1002/aja.1001320404 · Cited by 388 · see citing works

Endothelin Induced Contractility of Stellate Cells From Normal and Cirrhotic Rat Liver: Implications for Regulation of Portal Pressure and Resistance

Rockey, D. C., & Weisiger, R. A. (1996) · Hepatology · doi:10.1002/hep.510240137 · Cited by 386 · see citing works

Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis

Xia, J. Y., Holland, W. L., Kusminski, C. M., Sun, K., Sharma, A. X., Pearson, M. J., Sifuentes, A. J., McDonald, J. G., Gordillo, R., & Scherer, P. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.007 · Cited by 348 · see citing works

Transforming growth factor-β and substrate stiffness regulate portal fibroblast activation in culture

Li, Z., Dranoff, J. A., Chan, E. P., Uemura, M., Sévigny, J., & Wells, R. G. (2007) · Hepatology · doi:10.1002/hep.21792 · Cited by 336 · see citing works

Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer

Mori, M., Triboulet, R., Mohseni, M., Schlegelmilch, K., Shrestha, K., Camargo, F. D., & Gregory, R. I. (2014) · Cell · doi:10.1016/j.cell.2013.12.043 · Cited by 335 · see citing works

Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.

Selzner, M., Bielawska, A. E., Morse, M. A., Rüdiger, H. A., Sindram, D., Hannun, Y. A., & Clavien, P. (2001) · PubMed · Cited by 334 · see citing works

Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease

Moylan, C. A., Pang, H., Dellinger, A. E., Suzuki, A., Garrett, M. E., Guy, C. D., Murphy, S. K., Ashley‐Koch, A. E., Choi, S. S., Michelotti, G. A., et al. (2013) · Hepatology · doi:10.1002/hep.26661 · Cited by 316 · see citing works

Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes

Meikle, P. J., Wong, G., Barlow, C. K., Weir, J. M., Greeve, M. A., MacIntosh, G. L., Almasy, L. A., Comuzzie, A. G., Mahaney, M. C., Kowalczyk, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074341 · Cited by 308 · see citing works

Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liverPreprint

Benhamouche, S., Curto, M., Saotome, I., Gladden, A. B., Liu, C.-H., Giovannini, M., & McClatchey, A. I. (2010) · Genes & Development · doi:10.1101/gad.1938710 · Cited by 269 · see citing works

Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration

Pepe-Mooney, B. J., Dill, M. T., Alemany, A., Ordovas-Montanes, J., Matsushita, Y., Rao, A., Sen, A., Miyazaki, M., Anakk, S., Dawson, P. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.004 · Cited by 266 · see citing works

Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis

Yetukuri, L., Katajamaa, M., Medina‐Gómez, G., Seppänen‐Laakso, T., Vidal‐Puig, A., & Orešič, M. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-12 · Cited by 263 · see citing works

YAP and TAZ Regulate Skin Wound Healing

Lee, M.-J., Byun, M. R., Furutani‐Seiki, M., Hong, J., & Jung, H.-S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.339 · Cited by 257 · see citing works

Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts

Dooley, S., Delvoux, B., Lahme, B., Mangasser-Stephan, K., & Gressner, A. M. (2000) · Hepatology · doi:10.1053/he.2000.6126 · Cited by 229 · see citing works

PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis

Martin, K., Pritchett, J. P., Llewellyn, J., Mullan, A. F., Athwal, V. S., Dobie, R., Harvey, E., Zeef, L. A. H., Farrow, S. N., Streuli, C. H., et al. (2016) · Nature Communications · doi:10.1038/ncomms12502 · Cited by 220 · see citing works

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis

Haak, A. J., Kostallari, E., Sicard, D., Ligresti, G., Choi, K. M., Caporarello, N., Jones, D. L., Tan, Q., Meridew, J. A., Espinosa, A. M. D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6296 · Cited by 219 · see citing works

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice

Moya, I. M., Castaldo, S. A., den Mooter, L. V., Soheily, S., Sansores-García, L., Jacobs, J., Mannaerts, I., Xie, J., Verboven, E., Hillen, H., et al. (2019) · Science · doi:10.1126/science.aaw9886 · Cited by 219 · see citing works

Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation

Caliari, S. R., Perepelyuk, M., Cosgrove, B. D., Tsai, S. J., Lee, G. Y., Mauck, R. L., Wells, R. G., & Burdick, J. A. (2016) · Scientific Reports · doi:10.1038/srep21387 · Cited by 218 · see citing works

YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury

Planas-Paz, L., Sun, T., Pikiolek, M., Cochran, N. R., Bergling, S., Orsini, V., Yang, Z., Sigoillot, F., Jetzer, J., Syed, M., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.005 · Cited by 216 · see citing works

Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis

Kasumov, T., Li, L., Li, M., Gulshan, K., Kirwan, J. P., Liu, X., Previs, S. F., Willard, B. B., Smith, J. D., & McCullough, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126910 · Cited by 209 · see citing works

Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha

Desai, S. S., Tung, J. C., Zhou, V. X., Grenert, J. P., Malato, Y., Rezvani, M., Español‐Suñer, R., Willenbring, H., Weaver, V. M., & Chang, T. T. (2016) · Hepatology · doi:10.1002/hep.28450 · Cited by 185 · see citing works

Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury

Perepelyuk, M., Terajima, M., Wang, A. Y., Georges, P. C., Janmey, P. A., Yamauchi, M., & Wells, R. G. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00222.2012 · Cited by 184 · see citing works

Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study

Lemaître, R. N., Yu, C., Hoofnagle, A. N., Nair, H., Jensen, P. N., Fretts, A. M., Umans, J. G., Howard, B. V., Sitlani, C. M., Siscovick, D. S., et al. (2018) · Diabetes · doi:10.2337/db17-1449 · Cited by 179 · see citing works

Yap/Taz deletion in Gli(+) cell-derived myofibroblasts attenuates fibrosis

Liang, M., Yu, M., Xia, R., Song, K., Wang, J., Luo, J., Chen, G., & Cheng, J. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121354 · Cited by 169 · see citing works

Hepatocyte Stress Increases Expression of Yes‐Associated Protein and Transcriptional Coactivator With PDZ‐Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis

Mooring, M., Fowl, B. H., Lum, S. Z. C., Liu, Y., Yao, K., Softic, S., Kirchner, R., Bernstein, A., Singhi, A. D., Jay, D. G., et al. (2020) · Hepatology · doi:10.1002/hep.30928 · Cited by 162 · see citing works

Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis

Ballardini, G., Fallani, M., Biagini, G., Bianchi, F. B., & Pisi, E. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890000 · Cited by 150 · see citing works

Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition

Ji, C., Yang, B., Yang, Y.-L., He, S.-H., Miao, D.-S., He, L., & Bi, Z.-G. (2010) · Oncogene · doi:10.1038/onc.2010.379 · Cited by 149 · see citing works

Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease

Kurek, K., Ziembicka, D., Wiesiołek‐Kurek, P., Łukaszuk, B., Chabowski, A., Górski, J., & Żendzian‐Piotrowska, M. (2013) · Liver International · doi:10.1111/liv.12331 · Cited by 132 · see citing works

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

Samsel, L., Zaidel, G., Drumgoole, H. M., Jelovac, D., Drachenberg, C., Rhee, J. G., Brodie, A. M. H., Bielawska, A. E., & Smyth, M. J. (2003) · The Prostate · doi:10.1002/pros.10350 · Cited by 128 · see citing works

Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility

Li, C., Zheng, S., You, H., Liu, X., Lin, M., Yang, L., & Li, L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.028 · Cited by 125 · see citing works

Bcl‐2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes

Raisova, M., Goltz, G., Bektas, M., Bielawska, A. E., Riebeling, C., Hossini, A. M., Eberle, J., Hannun, Y. A., Orfanos, C. E., & Geilen, C. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02472-9 · Cited by 125 · see citing works

Precision-cut liver slices: a versatile tool to advance liver research

Palma, E., Doornebal, E. J., & Chokshi, S. (2019) · Hepatology International · doi:10.1007/s12072-018-9913-7 · Cited by 125 · see citing works

Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma

Han, S., Bai, E., Jin, G., He, C., Guo, X.-J., Wang, L., Li, M., Xia, Y., & Zhu, Q. (2014) · Journal of Immunology Research · doi:10.1155/2014/261365 · Cited by 124 · see citing works

Ceramide-mediated biology. Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs.

Bielawska, A. E., Linardic, C. M., & Hannun, Y. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36989-3 · Cited by 123 · see citing works

Hedgehog regulates yes‐associated protein 1 in regenerating mouse liver

Swiderska‐Syn, M., Xie, G., Michelotti, G. A., Jewell, M. L., Premont, R. T., Syn, W., & Diehl, A. M. (2016) · Hepatology · doi:10.1002/hep.28542 · Cited by 121 · see citing works

Precision-cut liver slices: A tool to model the liver ex vivo

Olinga, P., & Schuppan, D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.009 · Cited by 119 · see citing works

Regulation of organ size: Insights from the Drosophila Hippo signaling pathway

Kango-Singh, M., & Singh, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21996 · Cited by 117 · see citing works

TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts

Noguchi, S. F., Saito, A., Mikami, Y., Urushiyama, H., Horie, M., Matsuzaki, H., Takeshima, H., Makita, K., Miyashita, N., Mitani, A., et al. (2017) · Scientific Reports · doi:10.1038/srep42595 · Cited by 109 · see citing works

Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators

Lavado, A., He, Y. Y., Paré, J., Neale, G. A. M., Olson, E. N., Giovannini, M., & Cao, X. (2013) · Development · doi:10.1242/dev.096537 · Cited by 108 · see citing works

In vitro reversion of activated primary human hepatic stellate cells

Taghdouini, A. E., Najimi, M., Sancho‐Bru, P., Sokal, E. M., & van Grunsven, L. A. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0031-z · Cited by 90 · see citing works

Coordinated induction of drug transporters and phase I and II metabolism in human liver slices

Olinga, P., Elferink, M. G. L., Draaisma, A. L., Merema, M. T., Castell, J. V., Pérez, G., & Groothuis, G. M. M. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.01.008 · Cited by 88 · see citing works

TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma

Xiao, H., Jiang, N., Zhou, B., Liu, Q., & Du, C. (2014) · Cancer Science · doi:10.1111/cas.12587 · Cited by 85 · see citing works

Deregulation of Hippo–TAZ pathway during renal injury confers a fibrotic maladaptive phenotype

Anorga, S., Overstreet, J. M., Falke, L. L., Tang, J., Goldschmeding, R., Higgins, P. J., & Samarakoon, R. (2018) · The FASEB Journal · doi:10.1096/fj.201700722r · Cited by 85 · see citing works

Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector

Xu, J., Li, P.-X., Wu, J., Gao, Y., Yin, M.-X., Lin, Y., Yang, M., Chen, D., Sun, H., Liu, Z.-B., et al. (2015) · Clinical Science · doi:10.1042/cs20150385 · Cited by 79 · see citing works

TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression

Jorgenson, A. J., Choi, K. M., Sicard, D., Smith, K. M. J., Hiemer, S. E., Varelas, X., & Tschumperlin, D. J. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00205.2016 · Cited by 79 · see citing works

Hippo Signaling in the Liver – A Long and Ever-Expanding Story

Manmadhan, S., & Ehmer, U. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00033 · Cited by 77 · see citing works

Discovery and Evaluation of Inhibitors of Human Ceramidase

Draper, J. M., Xia, Z., Smith, R. A., Zhuang, Y., Wang, W., & Smith, C. D. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0365 · Cited by 75 · see citing works

TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells

Finch‐Edmondson, M., Strauss, R. P., Passman, A. M., Sudol, M., Yeoh, G. C., & Callus, B. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692285 · Cited by 74 · see citing works

The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis

Seo, E., Kim, W., Hur, J., Kim, H., Nam, S. A., Choi, A., Kim, Y., Park, S. H., Chung, C., Kim, J., et al. (2016) · Scientific Reports · doi:10.1038/srep31931 · Cited by 74 · see citing works

Novel analogs of d-e-MAPP and B13. Part 2: Signature effects on bioactive sphingolipids

Bielawska, A. E., Bielawski, J., Szulc, Z. M., Mayroo, N., Liu, X., Bai, A., Elojeimy, S. N., Rembiesa, B. M., Pierce, J. S., Norris, J. S., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.032 · Cited by 69 · see citing works

A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions

Bertero, T., Cottrill, K. A., Annis, S., Bhat, B., Gochuico, B. R., Osorio, J. C., Rosas, I. O., Haley, K. J., Corey, K. E., Chung, R. T., et al. (2015) · Scientific Reports · doi:10.1038/srep18277 · Cited by 65 · see citing works

Essential roles of sphingosine 1‐phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation

Liu, X., Yue, S., Li, C., Yang, L., You, H., & Li, L. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22572 · Cited by 64 · see citing works

ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation

Zhang, K., Chang, Y., Shi, Z., Han, X., Han, Y., Yao, Q., Hu, Z., Cui, H., Zheng, L., Han, T., et al. (2016) · Scientific Reports · doi:10.1038/srep30029 · Cited by 61 · see citing works

Induction of Endocytic Vesicles by Exogenous C6-ceramide

Li, R., Blanchette‐Mackie, E. J., & Ladisch, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21121 · Cited by 59 · see citing works

The adipokine/ceramide axis: Key aspects of insulin sensitization

Xia, J. Y., Morley, T. S., & Scherer, P. E. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52 · see citing works

Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver

van de Bovenkamp, M., Groothuis, G. M. M., Meijer, D. K. F., & Olinga, P. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.019 · Cited by 48 · see citing works

Construction of Conditional Acid Ceramidase Knockout Mice andin vivoEffects on Oocyte Development and Fertility

Eliyahu, E., Shtraizent, N., Shalgi, R., & Schuchman, E. H. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000341453 · Cited by 46 · see citing works

Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells

Ikeda, H., Yatomi, Y., Yanase, M., Satoh, H., Maekawa, H., Ogata, I., Ozaki, Y., Takuwa, Y., Mochida, S., & Fujiwara, K. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.2.g304 · Cited by 44 · see citing works

Increase of Ceramide in the Liver and Plasma after Carbon Tetrachloride Intoxication in the Rat

Ichi, I., Nakahara, K., Fujii, K., Iida, C., Miyashita, Y., & Kojo, S. (2007) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.53.53 · Cited by 32 · see citing works

Targeting (cellular) lysosomal acid ceramidase by B13: Design, synthesis and evaluation of novel DMG-B13 ester prodrugs

Bai, A., Szulc, Z. M., Bielawski, J., Pierce, J. S., Rembiesa, B. M., Terzieva, S. I., Mao, C., Xu, R., Wu, B. X., Clarke, C. J., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.10.025 · Cited by 31 · see citing works

Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells

Chen, J. Y., Newcomb, B., Zhou, C., Pondick, J. V., Ghoshal, S., York, S. R., Motola, D., Coant, N., Yi, J. K., Mao, C., et al. (2017) · Scientific Reports · doi:10.1038/srep44867 · Cited by 28 · see citing works

Functions of neutral ceramidase in the Golgi apparatus

Sakamoto, W., Coant, N., Canals, D., Obeid, L. M., & Hannun, Y. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088187 · Cited by 23 · see citing works

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 999 · see citing works

Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring

Mascharak, S., desJardins-Park, H. E., Davitt, M. F., Griffin, M., Borrelli, M. R., Moore, A. L., Chen, K., Duoto, B. A., Chinta, M. S., Foster, D. S., et al. (2021) · Science · doi:10.1126/science.aba2374 · Cited by 622 · see citing works

Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity

Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. A. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 517 · see citing works

Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression

Cai, X., Wang, K.-C., & Meng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673599 · Cited by 311 · see citing works

Hippo signalling in the liver: role in development, regeneration and disease

Russell, J. O., & Camargo, F. D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00571-w · Cited by 205 · see citing works

Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options

Grander, C., Grabherr, F., & Tilg, H. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad095 · Cited by 216 · see citing works

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works

Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment

McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146 · see citing works

MASH: the nexus of metabolism, inflammation, and fibrosis

Steinberg, G. R., Carpentier, A., & Wang, D.-D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186420 · Cited by 110 · see citing works

New Insights into Hippo/YAP Signaling in Fibrotic Diseases

Mia, M. M., & Singh, M. K. (2022) · Cells · doi:10.3390/cells11132065 · Cited by 116 · see citing works

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease

Hajduch, É., Lachkar, F., Ferré, P., & Foufelle, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040792 · Cited by 113 · see citing works

Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis

He, X., Tolosa, M. F., Zhang, T., Goru, S. K., Ulloa Severino, L., Misra, P. S., McEvoy, C. M., Caldwell, L., Szeto, S. G., Gao, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.146243 · Cited by 106 · see citing works

The pathophysiology of MASLD: an immunometabolic perspective

Schwärzler, J., Grabherr, F., Grander, C., Adolph, T. E., & Tilg, H. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2294046 · Cited by 102 · see citing works

YAP/TAZ: Molecular pathway and disease therapy

Wei, Y., Hui, V. L. Z., Chen, Y., Han, R., Han, X., & Guo, Y. (2023) · MedComm · doi:10.1002/mco2.340 · Cited by 93 · see citing works

Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling

Zhang, B., Zhang, Y., Zhang, J., Liu, P., Jiao, B., Wang, Z., & Ren, R. (2021) · Advanced Science · doi:10.1002/advs.202100250 · Cited by 83 · see citing works

NASH drug treatment development: challenges and lessons

Tilg, H., Byrne, C. D., & Targher, G. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00159-0 · Cited by 81 · see citing works

Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease

Mitten, E. K., & Baffy, G. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.028 · Cited by 81 · see citing works

circHIPK3 prevents cardiac senescence by acting as a scaffold to recruit ubiquitin ligase to degrade HuR

Ding, F., Lu, L., Wu, C., Pan, X., Liu, B., Zhang, Y., Wang, Y., Wu, W., Yan, B., Zhang, Y., et al. (2022) · Theranostics · doi:10.7150/thno.77630 · Cited by 81 · see citing works

Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis

Guo, Q., Furuta, K., Islam, S., Caporarello, N., Kostallari, E., Dielis, K., Tschumperlin, D. J., Hirsova, P., & Ibrahim, S. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983255 · Cited by 73 · see citing works

Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury

DiGiovanni, G. T., Han, W., Sherrill, T. P., Taylor, C. J., Nichols, D. S., Geis, N. M., Singha, U. K., Calvi, C. L., McCall, A. S., Dixon, M. M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.173374 · Cited by 69 · see citing works

Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β

Jiménez‐Uribe, A. P., Gómez‐Sierra, T., Aparicio‐Trejo, O. E., Orozco‐Ibarra, M., & Pedraza‐Chaverrí, J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110123 · Cited by 64 · see citing works

Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease

Zhu, C., Huai, Q., Zhang, X., Dai, H., Li, X., & Wang, H. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.78525 · Cited by 59 · see citing works

Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy

Sharip, A., & Kunz, J. (2025) · Cells · doi:10.3390/cells14040266 · Cited by 58 · see citing works

Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis

Thiele, M. S., Suvitaival, T., Trôst, K., Kim, M. G., de Zawadzki, A., Kjærgaard, M., Rasmussen, D. N., Lindvig, K. P., Israelsen, M. E., Detlefsen, S., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.023 · Cited by 57 · see citing works

Hyaluronic acid-modified and verteporfin-loaded polylactic acid nanogels promote scarless wound healing by accelerating wound re-epithelialization and controlling scar formation

Chen, K., Liu, Y. R., Liu, X., Guo, Y., Liu, J., Ding, J., Zhang, Z., Ni, X., & Chen, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02014-x · Cited by 57 · see citing works

Fibroblast Yap/Taz Signaling in Extracellular Matrix Homeostasis and Tissue Fibrosis

Chu, C., & Quan, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123358 · Cited by 59 · see citing works

Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis

Charan, H. V., Dwivedi, D. K., Khan, S., & Jena, G. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.006 · Cited by 55 · see citing works

Materials and extracellular matrix rigidity highlighted in tissue damages and diseases: Implication for biomaterials design and therapeutic targets

Park, J. H., Jo, S. B., Lee, J., Lee, H., Knowles, J. C., & Kim, H. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.06.003 · Cited by 49 · see citing works

Novel Therapeutic Targets in Liver Fibrosis

Zhang, J., Liu, Q., He, J., & Li, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.766855 · Cited by 46 · see citing works

The proteasome-dependent degradation of ALKBH5 regulates ECM deposition in PM2.5 exposure-induced pulmonary fibrosis of mice

Zhang, Y., Liu, Q., Ning, J., Jiang, T., Kang, A., Li, L., Pang, Y., Zhang, B., Huang, X., Wang, Q., et al. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128655 · Cited by 44 · see citing works

Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84

Ohue‐Kitano, R., Nonaka, H., Nishida, A., Masujima, Y., Takahashi, D., Ikeda, T., Uwamizu, A., Tanaka, M., Kohjima, M., Igarashi, M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.165469 · Cited by 43 · see citing works

Creeping fat-derived mechanosensitive fibroblasts drive intestinal fibrosis in Crohn’s disease strictures

Bauer-Rowe, K. E., Pham, B., Griffin, M., Liang, N. E., Kim, A., Lu, J. M., Januszyk, M., Guo, J. L., Santis, S. D., Xing, Y., et al. (2025) · Cell · doi:10.1016/j.cell.2025.08.029 · Cited by 38 · see citing works

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis

Liu, D., Li, Q., Zang, Y., Li, X., Li, Z., Zhang, P., Feng, C., Yang, P., Cui, J., Sun, Y., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05777-1 · Cited by 37 · see citing works

Role of TGF-β/SMAD/YAP/TAZ signaling in skeletal muscle fibrosis

Gallardo, F. S., Cruz-Soca, M., Bock-Pereda, A., Faundez-Contreras, J., Gutiérrez‐Rojas, C., Gandin, A., Torresan, V., Casar, J. C., Ravasio, A., & Brandan, E. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00541.2024 · Cited by 37 · see citing works

Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease

Ou, W., Xu, W., Liu, F., Guo, Y., Huang, Z., Feng, T., Liu, C., & Du, P. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103452 · Cited by 34 · see citing works

Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma

Gilgenkrantz, H., Paradis, V., & Lotersztajn, S. (2023) · Hepatology · doi:10.1097/hep.0000000000000479 · Cited by 31 · see citing works

The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ

Li, J., Dai, Y., Ge, H., Guo, S., Zhang, W., Wang, Y., Liu, L., Cheng, J., & Jiang, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05113-z · Cited by 33 · see citing works

Small extracellular vesicles with LncRNA H19 “overload”: YAP Regulation as a Tendon Repair Therapeutic Tactic

Tao, S., Huang, J., Li, Z.-X., Zhan, S., & Guo, S. (2021) · iScience · doi:10.1016/j.isci.2021.102200 · Cited by 29 · see citing works

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide

Wang, Y., Wang, X., Wang, X., Wu, D., Qi, J., Zhang, Y., Wang, K., Zhou, D., Meng, Q., Nie, E., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16874 · Cited by 29 · see citing works

Healing without scarring

Konieczny, P., & Naik, S. (2021) · Science · doi:10.1126/science.abi5770 · Cited by 29 · see citing works

Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance

Cui, J., Christin, J. R., Reisz, J. A., Cendali, F. I., Sanawar, R., de Miranda, M. C., D’Alessandro, A., & Guo, W. (2023) · Science Advances · doi:10.1126/sciadv.adh1891 · Cited by 27 · see citing works

Dynamic and static biomechanical traits of cardiac fibrosis

Liu, H., Fan, P., Jin, F., Huang, G., Guo, X., & Xu, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1042030 · Cited by 27 · see citing works

OPN‐Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH‐Associated Liver Fibrosis

Wang, S., Gao, J., Yang, M., Zhang, G., Yin, L., & Tong, X. (2024) · Advanced Science · doi:10.1002/advs.202405678 · Cited by 26 · see citing works

Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions

Kleynerman, A., Rybová, J., Faber, M. L., McKillop, W. M., Levade, T., & Medin, J. A. (2023) · Biomolecules · doi:10.3390/biom13020274 · Cited by 24 · see citing works

Emerging mechanomedicines informed by mechanotransduction along the integrin–cytoskeleton–nucleus axis

Yokoyama, Y., Domkam, N., Kabir, H., Mansour, A., Tsukamoto, S., Yerima, G., ADACHI, T., & Mofrad, M. R. K. (2025) · APL Bioengineering · doi:10.1063/5.0255473 · Cited by 23 · see citing works

Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation

Sharma, S. K., Prathigudupu, V., Cable, C., Serrano, L. R., Nerella, S., Chen, A., Hassan, G., Lakins, J. N., Lizama, C. O., Tsukui, T., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ads9470 · Cited by 23 · see citing works

From pulmonary fibrosis to progressive pulmonary fibrosis: a lethal pathobiological jump

Selman, M., & Pardo, A. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00310.2021 · Cited by 23 · see citing works

Disruption of adipocyte YAP improves glucose homeostasis in mice and decreases adipose tissue fibrosis

Han, D. J., Aslam, R., Misra, P. S., Chiu, F., Ojha, T., Chowdhury, A., Chan, C. K., Sung, H., Yuen, D. A., & Luk, C. T. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101594 · Cited by 22 · see citing works

Sphingolipids in embryonic development, cell cycle regulation, and stemness – Implications for polyploidy in tumors

Voelkel‐Johnson, C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.027 · Cited by 22 · see citing works

miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression

Fernández-Tussy, P., Cardelo, M. P., Zhang, H., Sun, J., Price, N. L., Boutagy, N. E., Goedeke, L., Cadena-Sandoval, M., Xirouchaki, C. E., Brown, W., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.168476 · Cited by 21 · see citing works

Cellular feedback dynamics and multilevel regulation driven by the hippo pathway

Park, J., & Hansen, C. G. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200253 · Cited by 18 · see citing works

Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease

Babiy, B., Ramos‐Molina, B., Ocaña, L., Sacristán, S., Burgos‐Santamaría, D., Martı́nez-Botas, J., Busto, R., Busto, R., Frutos, M. D., Albillos, A., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159318 · Cited by 25 · see citing works

Nobiletin Alleviated Epithelial–Mesenchymal Transition of Hepatocytes in Liver Fibrosis Based on Autophagy—Hippo/YAP Pathway

Hao, Y., Feng, D., Ye, H., & Liao, W. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300529 · Cited by 19 · see citing works

AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis

Shihan, M. H., Sharma, S. K., Cable, C., Prathigudupu, V., Chen, A. J., Mattis, A. N., & Chen, J. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55764-5 · Cited by 18 · see citing works

Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management

Adinolfi, L. E., Marrone, A., Rinaldi, L., Nevola, R., Izzi, A., & Sasso, F. C. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001281 · Cited by 18 · see citing works

Promising small molecule anti-fibrotic agents: Newly developed or repositioned drugs targeting myofibroblast transdifferentiation

Ishikane, S., Arioka, M., & Takahashi‐Yanaga, F. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115663 · Cited by 18 · see citing works

Signal Transduction and Molecular Regulation in Fatty Liver Disease

Dong, X. C., Chowdhury, K., Huang, M., & Kim, H.-G. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0076 · Cited by 18 · see citing works

May the best wound WIHN: the hallmarks of wound-induced hair neogenesis

Ankawa, R., & Fuchs, Y. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.10.006 · Cited by 17 · see citing works

YAP/TAZ as master regulators in liver regeneration and disease: insights into mechanisms and therapeutic targets

Ye, B., Yue, M., Hu, C., Sun, C., Shao, Y., Jin, Q., Zhang, C., & Yu, G. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10177-5 · Cited by 21 · see citing works

Celastrol Alleviates Corneal Stromal Fibrosis by Inhibiting TGF-β1/Smad2/3-YAP/TAZ Signaling After Descemet Stripping Endothelial Keratoplasty

Liu, R., Li, J., Guo, Z., Chu, D., Li, C., Shi, L., Zhang, J., Zhu, L., & Li, Z. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.3.9 · Cited by 17 · see citing works

Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms

Mitten, E. K., Portincasa, P., & Baffy, G. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00029 · Cited by 17 · see citing works

Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice

Xu, L., Wettschureck, N., Bai, Y., Yuan, Z., & Wang, S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.026 · Cited by 17 · see citing works

Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells

Li, W., Chen, J. Y., Sun, C., Sparks, R. P., Pantano, L., Rahman, R., Moran, S. P., Pondick, J. V., Kirchner, R., Wrobel, D., et al. (2022) · eLife · doi:10.7554/elife.74513 · Cited by 15 · see citing works

TKF, a mexicanolide-type limonoid derivative, suppressed hepatic stellate cells activation and liver fibrosis through inhibition of the YAP/Notch3 pathway

Yang, T., Wu, E., Zhu, X., Leng, Y., Ye, S., Dong, R., Liu, J., Zhong, J., Zheng, Y., Xu, W., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154466 · Cited by 14 · see citing works

The many pathways driving liver inflammation in MASH

Tilg, H., Adolph, T. E., Romeo, S., & Loomba, R. S. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.02.018 · Cited by 15 · see citing works

MitoQ alleviates carbon tetrachloride-induced liver fibrosis in mice through regulating JNK/YAP pathway

Shan, S., Liu, Z., Liu, Z., Zhang, C., & Song, F. (2022) · Toxicology Research · doi:10.1093/toxres/tfac062 · Cited by 14 · see citing works

Twist1 signaling in age-dependent decline in angiogenesis and lung regeneration

Hendee, K., Hunyenyiwa, T., Matus, K., Toledo, M., Mammoto, A., & Mammoto, T. (2021) · Aging · doi:10.18632/aging.202875 · Cited by 14 · see citing works

Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals

Zhao, Y., Wang, H., He, T., Ma, B., Chen, G., & Tzeng, C. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00775-6 · Cited by 13 · see citing works

Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma

Sun, Y.-D., Zhang, H., Li, Y., & Han, J. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189086 · Cited by 13 · see citing works

YAP as a potential therapeutic target for myofibroblast formation in asthma

Guo, Y., Zhou, Y., Wang, R., Lin, Y., Lan, H., Yang, L., Wang, D., Dong, J., Li, K., Yan, Y., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03115-x · Cited by 12 · see citing works

Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex

Aoyama, S., Kido, Y., Kanamoto, M., Naito, M., Nakanishi, M., Kanna, M., Yamamotoya, T., Asano, T., & Nakatsu, Y. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113544 · Cited by 11 · see citing works

Tension-induced organelle stress: an emerging target in fibrosis

Kai, F., Leidal, A. M., & Weaver, V. M. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.12.006 · Cited by 11 · see citing works

The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer

Zhong, B., Du, J., Liu, F., & Sun, S. (2025) · MedComm · doi:10.1002/mco2.70128 · Cited by 10 · see citing works

Effects of Diet and Exercise on Mitochondrial Health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Role of Ceramides

McCaffrey, J. M., & Ibdah, J. A. (2025) · Nutrients · doi:10.3390/nu17182972 · Cited by 12 · see citing works

Wedelolactone Attenuates Liver Fibrosis and Hepatic Stellate Cell Activation by Suppressing the Hippo Pathway

Zhang, W., Gao, K., Bai, Y., Xu, D., Zhao, M., Tao, X., & Wang, J. (2024) · Rejuvenation Research · doi:10.1089/rej.2024.0053 · Cited by 10 · see citing works

Knockdown of hepatic mitochondrial calcium uniporter mitigates MASH and fibrosis in mice

Li, S., Chen, F., Liu, M., Zhang, Y., Xu, J., Li, X., Shang, Z., Huang, S., Song, S., & Tu, C. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01315-4 · Cited by 10 · see citing works

YAP promotes fibrosis by regulating macrophage to myofibroblast transdifferentiation and M2 polarization in chronic pancreatitis

Tan, Q., Xiang, C., Zhang, H., Yuan, Y., Gong, S., Zheng, Z., Wang, X., Liu, X., Chen, Y., & 谭春路 (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114087 · Cited by 9 · see citing works

Reduction in and Preventive Effects for Oral-Cancer Risk with Antidepressant Treatment

Chung, C., Kuo, T., Yeh, K., Lee, C., & Ko, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070591 · Cited by 9 · see citing works

Roles of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in non-neoplastic liver diseases

Chen, D., Zhang, H., Zhang, X., Sun, X., Qin, Q., Hou, Y., Jia, M., & Chen, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113166 · Cited by 8 · see citing works

Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study

Xu, M., Gong, R., Xie, J., Xu, S., & Wang, S. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00927-y · Cited by 8 · see citing works

CD133‐Src‐TAZ signaling stimulates ductal fibrosis following DDC diet‐induced liver injury

Oh, H. T., Heo, W., Yoo, G. D., Kim, K. M., Hwang, J., Hwang, E. S., Ko, J., Ko, Y., & Hong, J. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30899 · Cited by 8 · see citing works

Recent Research Advances on the Hippo‐Yki Pathway of Crustaceans: Current Knowledge and Potential Applications in Crustacean Aquaculture

Yang, L., Gan, Y., Deng, H., He, J., & Xu, X. (2024) · Reviews in Aquaculture · doi:10.1111/raq.12955 · Cited by 7 · see citing works

Diminished nuclear‐localized β‐adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy

Xiang, W., Li, L., Qin, M., Li, L., Yu, H., Wang, F., Ni, S., Shen, A., Lu, H., Ni, H., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17347 · Cited by 7 · see citing works

Formononetin Mitigates Liver Fibrosis via Promoting Hepatic Stellate Cell Senescence and Inhibiting EZH2/YAP Axis.

Yuan, Z.-Q., Meng, J., Shen, X., Wang, M., Yu, Y., Shi, L., Li, Y.-L., Hassan, H. M., Li, H., He, Z.-X., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c05529 · Cited by 10 · see citing works

Emerging roles of the acid sphingomyelinase/ceramide pathway in metabolic and cardiovascular diseases: Mechanistic insights and therapeutic implications

Wang, H.-N., Wang, Y., Zhang, S., & Bai, L. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i2.102308 · Cited by 8 · see citing works

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis

Yu, A., Cable, C., Shihan, M. H., Sharma, S., Mattis, A. N., Mileva, I., Hannun, Y. A., Duwaerts, C. C., & Chen, J. Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.881848 · Cited by 7 · see citing works

Organ dependency on fascia connective tissue

Lin, Y., Dai, R., Vogelaar, G., & Rinkevich, Y. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00350.2024 · Cited by 7 · see citing works

Extracellular matrix stiffness regulates degradation of MST2 via SCF βTrCP

Fiore, A. P. Z. P., Rodrigues, A. M., Filho, H. V. R., Manucci, A. C., Ribeiro, P. D. F., Botelho, M. C. S., Vogel, C., de Oliveira, P. S. L., Pagano, M., & Bruni‐Cardoso, A. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130238 · Cited by 6 · see citing works

Chikusetsusaponin IVa targeted YAP as an inhibitor to attenuate liver fibrosis and hepatic stellate cell activation

Gao, K., Zhang, W., Xu, D., Zhao, M., Tao, X., Lu, Y., & Wang, J. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01090-5 · Cited by 6 · see citing works

Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells

Li, W., Sparks, R. P., Sun, C., Yang, Y., Pantano, L., Kirchner, R., Arghiani, N., Weilheimer, A., Toles, B. J., Chen, J. Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56900-z · Cited by 5 · see citing works

Hepatocyte Growth Factor-Modified Dental Pulp Stem Cells Potentially Regulate Novel Renal Fibrosis-Associated Gene via PI3K/AKT/GSK3β Pathway to Alleviate Renal Fibrosis

Shao, J., Xu, W., Tao, N., Du, H., He, Z., Wang, L., Wu, C.-T., & Wang, H. (2025) · Human Gene Therapy · doi:10.1089/hum.2025.044 · Cited by 4 · see citing works

Multiomics reveals metformin’s dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention

Sun, Y.-D., Zhang, H., Gong, X.-L., Li, Y., Han, R., Zhou, C., & Han, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-07557-7 · Cited by 4 · see citing works

Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment

Wang, H.-Y., Qi, M.-M., Zhang, K., Zhu, Y.-Z., & Zhang, J. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i34.108617 · Cited by 4 · see citing works

Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway

Ulusan, M., Erdoğan, M. A., ŞİMŞEK, Ö., Dogan, Z., Ciftci, B. B., Atalan, G., & Erbaş, O. (2025) · Medicina · doi:10.3390/medicina61050857 · Cited by 4 · see citing works

Hippo-YAP/TAZ signaling in gastric cancer: molecular pathogenesis and emerging therapeutic horizons

Kaur, M., Mungurere, R. F., Mitinje, N., Sethi, G. K., Kaur, A. S., & Mishra, A. (2026) · Medical Oncology · doi:10.1007/s12032-026-03246-1 · Cited by 3 · see citing works

Mechanical network motifs as targets for mechanomedicine

Lu, M., Zhao, X., Xu, F., Yin, C., Guo, H., & Cheng, B. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104145 · Cited by 3 · see citing works

Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progressionPreprint

Fernández-Tussy, P., Sun, J., Cardelo, M. P., Price, N., Goedeke, L., Xirouchaki, C. E., Yang, X.-Y., Pastor-Rojo, O., Bennett, A., Tiganis, T., et al. (2023) · bioRxiv · doi:10.1101/2023.01.18.523503 · Cited by 5 · see citing works

Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis

Xie, S.-S., & Liu, Z.-G. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i46.113298 · Cited by 2 · see citing works

Experimental Workflow for Preclinical Studies of Human Antifibrotic Therapies

Reolizo, L., Matsuda, M., & Seki, E. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3207-9_18 · Cited by 2 · see citing works

Small-molecule natural products for reversing liver fibrosis based on modulation of HSCs activation: an updatePreprint

Zheng, Y., Yang, Z., Luo, K., & Li, X. (2022) · doi:10.22541/au.166542685.54449876/v1 · Cited by 2 · see citing works

Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells

Chen, J. Y., Newcomb, B., Zhou, C., Pondick, J. V., Ghoshal, S., York, S. R., Motola, D., Coant, N., Yi, J. K., Mao, C., et al. (2017) · Scientific Reports · doi:10.1038/srep44867 · Cited by 28 · see citing works

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis

Yu, A., Cable, C., Shihan, M. H., Sharma, S., Mattis, A. N., Mileva, I., Hannun, Y. A., Duwaerts, C. C., & Chen, J. Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.881848 · Cited by 7 · see citing works

AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis

Shihan, M. H., Sharma, S. K., Cable, C., Prathigudupu, V., Chen, A. J., Mattis, A. N., & Chen, J. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55764-5 · Cited by 18 · see citing works

Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation

Sharma, S. K., Prathigudupu, V., Cable, C., Serrano, L. R., Nerella, S., Chen, A., Hassan, G., Lakins, J. N., Lizama, C. O., Tsukui, T., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ads9470 · Cited by 23 · see citing works

Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice

Quillin, R. C., Wilson, G. C., Nojima, H., Freeman, C. M., Wang, J., Schuster, R. M., Blanchard, J. A., Edwards, M. J., Gandhi, C. R., Gulbins, E., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12352 · Cited by 25 · see citing works